Debabrata Mukhopadhyay Selected Research

Neuropilin-1

1/2022	Neuropilin-1 deficiency in vascular smooth muscle cells is associated with hereditary hemorrhagic telangiectasia arteriovenous malformations.
11/2020	Ablation of neuropilin-1 improves the therapeutic response in conventional drug-resistant glioblastoma multiforme.
1/2019	Neuropilin-1 maintains dimethylarginine dimethylaminohydrolase 1 expression in endothelial cells, and contributes to protection from angiotensin II-induced hypertension.
1/2019	Genetic status of KRAS influences Transforming Growth Factor-beta (TGF-β) signaling: An insight into Neuropilin-1 (NRP1) mediated tumorigenesis.
10/2017	Genetic status of KRAS modulates the role of Neuropilin-1 in tumorigenesis.
6/2015	Cardiomyopathy and Worsened Ischemic Heart Failure in SM22-α Cre-Mediated Neuropilin-1 Null Mice: Dysregulation of PGC1α and Mitochondrial Homeostasis.
8/2012	VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression.
8/2012	Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment.
7/2010	Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells.
11/2008	Neuropilin-1 upholds dedifferentiation and propagation phenotypes of renal cell carcinoma cells by activating Akt and sonic hedgehog axes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Debabrata Mukhopadhyay Research Topics

Disease

70	Neoplasms (Cancer) 06/2022 - 02/2003
34	Pancreatic Neoplasms (Pancreatic Cancer) 06/2022 - 02/2003
15	Hypoxia (Hypoxemia) 02/2014 - 01/2004
13	Pathologic Constriction (Stenosis) 01/2020 - 12/2005
12	Adenocarcinoma 06/2022 - 02/2003
12	Hyperplasia 10/2017 - 01/2008
11	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 01/2004
9	Arteriovenous Fistula 01/2020 - 02/2008
9	Neoplasm Metastasis (Metastasis) 12/2019 - 10/2004
9	Kidney Neoplasms (Kidney Cancer) 01/2019 - 01/2004
7	Carcinogenesis 12/2019 - 11/2008
7	Type 2 Diabetes Mellitus (MODY) 07/2013 - 03/2006
6	Inflammation (Inflammations) 01/2022 - 03/2005
6	Chronic Renal Insufficiency 01/2021 - 10/2006
6	Breast Neoplasms (Breast Cancer) 12/2016 - 12/2010
5	Fibrosis (Cirrhosis) 01/2020 - 07/2010
4	Liver Cirrhosis (Hepatic Cirrhosis) 12/2017 - 07/2010
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2011 - 05/2007
3	Edema (Dropsy) 01/2022 - 08/2005
3	Pancreatitis 01/2021 - 02/2011
3	Glioblastoma (Glioblastoma Multiforme) 11/2020 - 01/2014
3	Lung Neoplasms (Lung Cancer) 10/2017 - 10/2014
3	Ovarian Neoplasms (Ovarian Cancer) 10/2014 - 04/2004
3	Vascular Remodeling 02/2014 - 08/2010
3	Fistula 02/2014 - 04/2008
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 01/2014
2	Glioma (Gliomas) 11/2020 - 09/2019
2	Colonic Neoplasms (Colon Cancer) 10/2019 - 12/2016
2	Hyperglycemia 01/2019 - 04/2011
2	Portal Hypertension 05/2014 - 07/2010
2	Insulin Resistance 12/2012 - 11/2007
2	Pulmonary Edema 01/2012 - 03/2005

Drug/Important Bio-Agent (IBA)

37	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 07/2002
17	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2004
15	Pharmaceutical PreparationsIBA 01/2021 - 03/2010
12	Neuropilin-1IBA 01/2022 - 12/2003
10	Gemcitabine FDA Link 11/2019 - 03/2008
9	Peptides (Polypeptides)IBA 02/2022 - 06/2009
9	Small Interfering RNA (siRNA)IBA 11/2019 - 06/2009
9	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 07/2002
6	GoldIBA 01/2022 - 05/2007
6	CytokinesIBA 07/2021 - 08/2005
6	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 08/2010
6	Messenger RNA (mRNA)IBA 12/2017 - 01/2004
6	Insulin (Novolin)FDA Link 12/2012 - 07/2002
5	LigandsIBA 01/2022 - 05/2014
5	Liposomes (Liposome)IBA 10/2020 - 03/2016
5	LipidsIBA 01/2019 - 03/2011
5	Polytetrafluoroethylene (Teflon)FDA Link 08/2009 - 02/2008
4	Phosphotransferases (Kinase)IBA 07/2021 - 02/2011
4	Biomarkers (Surrogate Marker)IBA 10/2019 - 07/2013
4	Therapeutic UsesIBA 01/2019 - 10/2011
4	Matrix Metalloproteinase 2 (Gelatinase A)IBA 06/2010 - 12/2005
3	AntibodiesIBA 01/2022 - 08/2005
3	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 04/2012
3	Glycogen Synthase KinasesIBA 11/2019 - 06/2010
3	Transforming Growth Factor beta (TGF-beta)IBA 01/2019 - 07/2010
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2015 - 03/2006
3	AdrenomedullinIBA 04/2015 - 12/2012
3	IntegrinsIBA 07/2013 - 11/2007
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2011 - 08/2004
3	Tissue Inhibitor of Metalloproteinase-1IBA 05/2008 - 02/2008
3	progelatinaseIBA 05/2008 - 02/2008
2	EndoglinIBA 01/2022 - 10/2014
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022 - 08/2012
2	Glycogen Synthase (Synthase I)IBA 07/2021 - 11/2019
2	LipopolysaccharidesIBA 01/2021 - 01/2012
2	benzamideIBA 01/2021 - 01/2021
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2020 - 07/2002
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2020 - 01/2016
2	CateninsIBA 12/2019 - 03/2015
2	MicroRNAs (MicroRNA)IBA 12/2019 - 11/2009
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2019 - 01/2019
2	NanodiamondsIBA 11/2019 - 01/2019
2	Glycogen Synthase Kinase 3IBA 11/2019 - 02/2014
2	Semaphorins (Semaphorin)IBA 01/2019 - 07/2013
2	LipopeptidesIBA 01/2019 - 10/2014
2	Everolimus FDA Link 01/2019 - 01/2019
2	TOR Serine-Threonine KinasesIBA 01/2019 - 03/2010
2	CholesterolIBA 01/2019 - 01/2019
2	thiamine triphosphorate (TTP)IBA 01/2019 - 01/2019
2	Vinorelbine (Navelbine)FDA LinkGeneric 01/2019 - 03/2010
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2017 - 02/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2017 - 01/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2017 - 10/2011
2	plumbaginIBA 01/2016 - 03/2013
2	Angiogenesis InhibitorsIBA 05/2015 - 03/2013
2	Conditioned Culture MediaIBA 04/2015 - 12/2012
2	Protein CIBA 10/2014 - 01/2014
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2014 - 07/2011
2	Neutralizing AntibodiesIBA 05/2014 - 03/2010
2	Fibronectins (Fibronectin)IBA 08/2012 - 06/2010
2	Dopamine (Intropin)FDA LinkGeneric 01/2012 - 08/2004
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 07/2011 - 11/2005
2	Bromodeoxyuridine (BrdU)IBA 04/2011 - 10/2004

Therapy/Procedure

18	Therapeutics 07/2021 - 10/2004
15	Renal Dialysis (Hemodialysis) 01/2020 - 12/2005
8	Drug Therapy (Chemotherapy) 06/2022 - 03/2011
2	Immunotherapy 01/2017 - 08/2005
2	Transplantation 05/2016 - 01/2009